Predict your next investment

Diversified Financial Services
symbioticsgroup.com

See what CB Insights has to offer

Investments

15

Portfolio Exits

1

Partners & Customers

1

About Symbiotics

Symbiotics is an investment company specialized in emerging inclusive finance.

Symbiotics Headquarter Location

Rue de la Synagogue 31

Geneva, 1204,

Switzerland

+41 223381540

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Symbiotics News

Symbiotics and Oikocredit in debt deal with ETG trading unit

Nov 29, 2021

for access to: Africa’s private capital deals, fund raises and the investment firms and executives involved Portfolio company news that impacts value and stakeholder participation Job moves and partnerships between leading market participants Exclusive access to Africa Capital Digest’s full content archive If you’d like more information on exceptional value group subscriptions for your colleagues and teams, please contact Teresa Hall at thall[at]africacapitaldigest.com today.

Symbiotics Investments

15 Investments

Symbiotics has made 15 investments. Their latest investment was in Tugende as part of their Debt on December 12, 2021.

CBI Logo

Symbiotics Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

12/20/2021

Debt

Tugende

$17M

Yes

1

11/25/2021

Loan - II

Export Trading Group

$30.8M

Yes

1

7/30/2021

Debt - V

Samunnati

$4.6M

No

2

9/22/2020

Series E

Subscribe to see more

Subscribe to see more

10

9/17/2020

Debt

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/20/2021

11/25/2021

7/30/2021

9/22/2020

9/17/2020

Round

Debt

Loan - II

Debt - V

Series E

Debt

Company

Tugende

Export Trading Group

Samunnati

Subscribe to see more

Subscribe to see more

Amount

$17M

$30.8M

$4.6M

$99M

New?

Yes

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

1

2

10

10

Symbiotics Portfolio Exits

1 Portfolio Exit

Symbiotics has 1 portfolio exit. Their latest portfolio exit was Finsocial on May 04, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

5/4/2021

Acq - Fin

1

Date

5/4/2021

Exit

Acq - Fin

Companies

Valuation

Acquirer

Sources

1

Symbiotics Partners & Customers

1 Partners and customers

Symbiotics has 1 strategic partners and customers. Symbiotics recently partnered with Consultative Group to Assist the Poor on November 11, 2020.

Date

Type

Business Partner

Country

News Snippet

Sources

11/16/2020

Partner

Consultative Group to Assist the Poor

United States

CGAP, Symbiotics Partner to Monitor COVID-19’s Impact on Microfinance.

As the survey wraps up , this new partnership with Symbiotics will enable us to continue providing valuable data on an ongoing basis and with a focus on longer-term concerns , '' said Peter Zetterli , who led the pulse survey effort for CGAP .

1

Date

11/16/2020

Type

Partner

Business Partner

Consultative Group to Assist the Poor

Country

United States

News Snippet

CGAP, Symbiotics Partner to Monitor COVID-19’s Impact on Microfinance.

As the survey wraps up , this new partnership with Symbiotics will enable us to continue providing valuable data on an ongoing basis and with a focus on longer-term concerns , '' said Peter Zetterli , who led the pulse survey effort for CGAP .

Sources

1

Symbiotics Team

2 Team Members

Symbiotics has 2 team members, including current Chief Executive Officer, Roland Dominicé.

Name

Work History

Title

Status

Roland Dominicé

Chief Executive Officer

Current

Sébastien Duquet

Chief Investment Officer

Former

Name

Roland Dominicé

Sébastien Duquet

Work History

Title

Chief Executive Officer

Chief Investment Officer

Status

Current

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.